Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.
Sofia DoubrovinskaiaChristoph M MooshageCorinna SeligerHanns-Martin LorenzSimon NagelPascal LehnertJan Christoph PurruckerBrigitte WildemannMartin BendszusWolfgang WickSilvia SchoenenbergerLeon D KaulenPublished in: European journal of neurology (2022)
In this study long-term characteristics of neurological autoimmunity encountered after SARS-CoV-2 vaccinations are defined. Outcome was favorable in most cases. Re-vaccinations were well tolerated and should be considered on an individual risk/benefit analysis.